Nebulized amphotericin B combined with intravenous amphotericin B in rats with severe invasive pulmonary aspergillosis.
May 2006
Article
volume 50, issue 5 pp 1852-1854.
| Related Files |
|---|
|
Redirect to publisher's version
(publisher's version.url.txt, 50 bytes) |
Repository contains one additional file which is not publicly available
Nebulized amphotericin B (AMB) combined with intravenous AMB was studied in persistently leukopenic rats with invasive pulmonary aspergillosis. Pulmonary concentrations of AMB after aerosol treatment were substantially higher than after intravenous liposomal AMB. Nebulized liposomal AMB in addition to intravenous AMB resulted in significantly prolonged survival compared to controls.
Keywords
- Animals
- Treatment Outcome
- Rats
- Amphotericin B/*administration & dosage/pharmacology
- Antibiotics, Antifungal/*administration & dosage/pharmacology
- Aspergillosis/*drug therapy
- Biological Markers/metabolism
- Injections, Intravenous
- Liposomes
- Aspergillus fumigatus/*drug effects
- Lung Diseases, Fungal/*drug therapy/microbiology
- Nebulizers and Vaporizers/microbiology
- Severity of Illness Index
